Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 36,628 shares at $63.21 ($2.2M) on 2018-11-19, disclosed to the SEC on 2018-11-21.
Open-market sale of $2.2M RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.08 | 2,761 | $158K | 7.2% |
| 2 | $57.08 | 2,761 | $158K | 7.2% |
| 3 | $58.37 | 2,300 | $134K | 6.2% |
| 4 | $59.61 | 9,092 | $542K | 24.9% |
| 5 | $59.61 | 9,092 | $542K | 24.9% |
| 6 | $60.25 | 4,361 |
| $263K |
| 12.1% |
| 7 | $60.25 | 4,361 | $263K | 12.1% |
| 8 | $61.55 | 800 | $49K | 2.3% |
| 9 | $63.21 | 1,100 | $70K | 3.2% |
| Total | $59.45 avg | 36,628 | $2.2M | 100% |
| Filing → |
| RGNX | SELL | 2018-10-31 | $2.3M | — | Filing → |
| RGNX | SELL | 2018-10-17 | $1.9M | — | Filing → |
| RGNX | SELL | 2017-09-12 | $684K | — | Filing → |